MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


TRADING UPDATES: Microsaic completes acquisition; Narf revenue soars

ALN

The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Kavango Resources PLC - Southern Africa-focused metals explorer - Prepares to commence drilling a fourth prospect at the Hillside Gold Project in Zimbabwe. Target depth is 250m to test a number of possible gold-bearing structures. Results aim to inform possible follow-up drilling, targeting a bulk-mineable gold discovery. Chief Executive Ben Turney says: ‘There is enormous, unrealised potential in the goldfields of Zimbabwe.’

----------

Hummingbird Resources PLC - West Africa-focused and Birmingham, England-based gold producer, developer and explorer - Provides an update on operations at its Kouroussa Gold Mine. Reports mining operations at Kouroussa are restarting shortly and are expected to ramp up to full capacity levels over the coming weeks. This follows temporary suspension due to a fire. Remains focused on reaching full commercial production in the first quarter.

----------

Faron Pharmaceuticals Ltd - Turku, Finland-based clinical-stage biopharmaceutical company specialising in cancer therapies - Reports patients are currently being enrolled in the Phase 2 of the Bexmab trial, which is evaluating the safety and efficacy of investigational immunotherapy bexmarilimab at two dose levels. In the meantime, further analysis of Phase 1 showed a 100% overall response rate achieved among both the higher-risk frontline and HMA-failed myelodysplastic syndrome patients treated with a bexmarilimab/azacitidine combination.

----------

NARF Industries PLC - London-based cybersecurity group which specialises in high-end threat intelligence and critical infrastructure security - Reports that revenue more than doubles to $6.0 million in 2023 from $2.5 million. Swings to positive earnings before interest, tax, depreciation and amortisation, from a $2.6 million loss in 2022.

----------

Microsaic Systems PLC - Surrey-based developer of real-time mass spectrometers - Completes the £100,000 acquisition of the modern water assets and the Microtox water testing business previously owned by DeepVerge PLC. Deal was announced on January 12.

----------

Copyright 2024 Alliance News Ltd. All Rights Reserved.